Startups

Knox Systems: $25 Million Raised To Accelerate AI-Managed Cloud And 90-Day FedRAMP Authorization

By Amit Chowdhry ● Mar 17, 2026

Knox Systems, the largest federal AI-managed cloud provider, announced it has raised $25 million in Series A funding to scale its platform and accelerate access to federal markets for commercial software providers. The round was led by B Capital, with participation from M12, Microsoft’s venture fund, Okta Ventures, MongoDB Ventures, Hearst Ventures, and Benchstrength, along with previous investors Felicis, Ridgeline, and FirsthandVC.

Gradient: $220 Million Raised For AI Seed Fund

By Amit Chowdhry ● Mar 17, 2026

Gradient, an early-stage venture capital firm focused on artificial intelligence startups, announced it has closed its fifth flagship seed fund, totaling $220 million, bringing its total assets under management to nearly $1.2 billion across five funds. Founded in 2017, the firm has positioned itself as one of the earliest dedicated AI venture funds, investing at the pre-seed and seed stages across applications, agentic platforms, and AI-powered real-world systems.

Definity: $7 Million Raised For Healthcare Workforce Management Platform

By Amit Chowdhry ● Mar 17, 2026

Definity, a vendor-neutral healthcare workforce platform, announced it has raised $7 million in Series A funding led by Accrete Health Partners, the digital venture arm of Bon Secours Mercy Health, with participation from additional investors.

Conduit Health: $17 Million Raised For Insurance-Covered Medical Supplies Platform Expansion

By Amit Chowdhry ● Mar 17, 2026

Conduit Health announced that it has raised $17 million in a Series A funding round to expand its vertically integrated platform that streamlines access to insurance-covered medical supplies for Medicare and Medicaid patients. The round was led by Drive Capital with participation from prior investors XYZ Ventures, Twelve Below, and Eniac Ventures, bringing the company’s total funding to $22 million.

R1 Therapeutics: $77.5 Million Raised To Advance Kidney Disease Treatment

By Amit Chowdhry ● Mar 17, 2026

R1 Therapeutics, a clinical-stage biopharmaceutical company focused on kidney disease, has launched with an oversubscribed $77.5 million Series A financing to advance a first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease.

Mestag Therapeutics: $40 Million Raised To Advance Fibroblast Immunology Cancer Therapies Into Clinic

By Amit Chowdhry ● Mar 17, 2026

Mestag Therapeutics, a biotech company focused on fibroblast immunology, has announced the closing of a $40 million financing round, bringing its total funding to more than $95 million. The round was backed by SV Health Investors, Johnson & Johnson Innovation – JJDC, Inc., Forbion, GV (Google Ventures), and Northpond Ventures.

Sequential: $3.5 Million Raised By Skin Microbiome Testing Company For AI-Powered Discovery Platform

By Amit Chowdhry ● Mar 17, 2026

Sequential, a genomic testing company focused on non-invasive human clinical samples, announced it has raised $3.5 million in its first equity funding round, bringing its total funding to $7.5 million, including both dilutive and non-dilutive capital.